Steve Vintz
Analyst · Morgan Stanley. Please proceed with your question
Thanks, Amit. As Amit mentioned earlier, we are delighted with our results for the first quarter, highlighted by 31% growth in calculated current billings, an EPS and continued investment in innovation and distribution. I will provide more commentary on each of these points momentarily. But first, please note that all financial results we discuss today are non-GAAP financial measures with the exception of revenue. As Erin mentioned, at the start of this call, GAAP to non-GAAP reconciliations may be found in our earnings release issued earlier today, which is posted on our website. Now on to the results for the quarter. Revenue for the quarter was $159.4 million, which represents 29% year-over-year growth, which is up from 20% growth in Q1 last year and 26% growth last quarter. Revenue in the quarter exceeded the midpoint of our guided range by $6.4 million. We are delighted with the results for the quarter and the very sizable beat in revenue. Please note that approximately $1.4 million of revenue recognized in the quarter was due to the early termination of customer contracts in Russia and Belarus as a result of sanctions and export restrictions imposed by the U.S. government. This is revenue that largely would have been recognized over the ensuing quarters this year, but had little impact on CCB this quarter as the value of these contracts were already reflected in the current portion of deferred revenue. Visibility remains high as our percentage of recurring revenue was 95%, which is primarily a result of our annual prepaid subscription model. The outperformance in revenue is a result of continued accelerating growth in calculated current billings. CCB, defined as the change in current portion of deferred revenue plus revenue recognized in the quarter, grew 31% year-over-year to $156.5 million. This is our fourth consecutive quarter of accelerating CCB growth, which started from a base of 20% CCB growth in Q1 last year. We attribute this inflection in growth to our market leadership in VM, expanded product portfolio and increased innovation and go-to-market activities. More specifically, the heightened threat environment has highlighted the need for our customers to continuously map and measure their cyber exposure across the attack surface. This is evidenced by the strength in new business this quarter as new enterprise platform customers grew 39% year-over-year. In particular, demand was very strong in North America as well as internationally in both the large and mid-market. In terms of product mix, our exposure platform, Tenable.ep, which now includes cloud and identity security, benefited from customers seeking broader awareness of risk across their attack surface. Upsell from existing customers was also substantial in the quarter, which combined with robust renewals resulted in an LTM net dollar expansion rate that was notably above our historical rates over the last two years. This was aided in part by Log4j, although to a lesser extent than what we experienced in Q4. I'll now turn to expenses, which include incremental investments in growth and the additional operating expenses related to the Cymptom acquisition that we closed in February. I'll start with gross margin, which was 81% this quarter compared to 82% last quarter. Cost of sales increased sequentially due to higher public cloud costs associated with increased usage from our products and incremental investment in infrastructure to support new analytics for our exposure platform. As Amit mentioned earlier, we plan to launch a more expansive set of cyber exposure analytics, which we currently expect to be in the second half of the year. This will include attack path analysis via newly acquired Cymptom, enhanced and unified analytics and improved benchmarking and contextualization of vulnerabilities, all of which will help customers better visualize and efficiently manage risk across their hybrid environments. As we've indicated in the past, we expect these investments, a portion of which are upfront costs to modestly impact gross margin short-term, but provide increased scalability to support future growth. Long term, we still expect gross margins to be in the high 70% to low 80% range. Sales and marketing expense for the quarter was $71.5 million, which was up from $69.5 million last quarter. Sales and marketing expense includes higher wages, draws and benefits related to hiring more quota-carrying sales reps and other headcount in the quarter as well as higher commissions attributed to our strong sales performance in the quarter. Sales and marketing expense as a percent of revenue was 45% in Q1 compared to 47% last quarter. R&D expense for the quarter was $27.8 million, which is up from $24.9 million last quarter. It should be noted that we added a team of engineers in connection with the Cymptom acquisition and made incremental investments in engineering in support of our expanding product portfolio, which was offset in part by capitalized software development costs in the quarter. R&D expense as a percentage of revenue was 17% in Q1, which is consistent with last quarter. G&A expense was $16.6 million compared to $15.8 million last quarter. We continue to make investments in information technology and in resources, recruiting, in particular, to support the growth and scale of our business. As a percent of revenue, G&A expense was 10% this quarter compared to 11% last quarter as well as for the full year 2021. Income from operations was $12.5 million compared to $11.9 million last quarter, which reflects the items I just highlighted. Operating margin was 8% for Q1 and last quarter. EPS in the first quarter was $0.06, which is $0.01 better than the high end of our guided range, and this is after absorbing approximately $0.01 of expense related to FX remeasurement, which is included in other expense in the income statement. Now let's turn to the balance sheet. We finished the quarter with $526.1 million in cash and short-term investments. Accounts receivable was $96.4 million and total deferred revenue was $527.5 million, including $404.8 million of current deferred revenue, which gives us a lot of visibility headed into 2022. Now I would like to discuss cash flow. We paid $4.1 million of cash interest on our credit facility in the first quarter. Looking ahead, we are assuming a higher interest rate environment, which will increase the interest expense on our floating rate debt facility when a reset at the end of July. Consequently, our full year guidance reflects $15.7 million of interest expense, which is $1.7 million higher than our previously provided guidance. That said, our Term Loan B continues to provide a low cost of capital, which has allowed us to fund acquisitions without the equity dilution to our shareholders. In Q1, we generated $32.1 million of unlevered free cash flow, with 95% recurring revenue, attractive gross margins and high renewal rates, we feel confident that we can continue to generate attractive levels of cash flow while continuing to invest in the business. Striking the right balance between growth and profitability has always been and will continue to be an area of focus for us. Last year, we became a Rule of 40 company, and we are well on our way to achieving the Rule of 50 target we outlined at our Investor Day in December. With the results of the quarter behind us, I'd like to discuss our outlook in the second quarter and the full year 2022. For the second quarter, we currently expect revenue to be in the range of $162 million to $164 million. Non-GAAP income from operations to be in the range of $6 million to $7 million; non-GAAP net income to be in the range of $1 million to $2 million, assuming interest expense of $3.5 million and a provision for income taxes of $1.6 million; non-GAAP diluted earnings per share to be in the range of $0.01 to $0.02, assuming 119.5 million fully diluted weighted average shares outstanding. And for the full year, we currently expect calculated current billings to be in the range of $764 million to $772 million, revenue to be in the range of $673 million to $679 million, non-GAAP income from operations to be in the range of $44 million to $48 million, non-GAAP net income to be in the range of $19.5 million to $23.5 million, assuming interest expense of $15.7 million and a provision for income taxes of $8 million; non-GAAP diluted earnings per share to be in the range of $0.16 to $0.20, assuming 119.5 million fully diluted weighted average shares outstanding. I'd like to discuss a few remarks regarding our guidance today. In terms of topline growth, our guidance contemplates a more normalized spending environment, reflecting the reduced impact from tailwinds such as Log4j. As a reminder, hiring and investment for us is typically weighted towards the first half of the year, which results in lower operating margins in Q2 and higher operating margins in the second half of the year. This seasonal expense flow is something we discussed on our last call and is reflected in the outlook for the second quarter. Also, as announced today in a separate press release, we entered into a definitive agreement to acquire Bit Discovery, an attack surface management company. The acquisition is not expected to close until later in the quarter and is therefore not expected to have a significant impact on our financial outlook for Q2. For the second half of the year, revenue is not expected to be significant, but we expect Bit Discovery to add $2 million to $3 million of CCB, most notably in the latter part of the year, and $2 million to $3 million of non-GAAP net loss. The impact of the acquisition of Bit Discovery is not reflected in our outlook today. In summary, we are delighted with the results for the quarter. We're off to a great start to the year, and we feel really good about the outlook we are providing today. I'll now turn the call back to Amit for some closing comments.